Related Experiment Video
Updated: Jun 15, 2026

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas
Published on: July 25, 2025
Consequences of a compromised intrauterine environment on islet function
Alice S Green1, Paul J Rozance, Sean W Limesand
1Department of Animal Sciences, University of Arizona, 1650 East Limberlost Drive, Tucson, Arizona 85719, USA.
Low birth weight, often caused by intrauterine growth restriction (IUGR), may lead to persistent beta-cell defects. This can result in impaired glucose tolerance and diabetes later in life.
Area of Science:
- Endocrinology
- Developmental Biology
- Metabolic Disease Research
Background:
- Low birth weight and intrauterine growth restriction (IUGR) are linked to impaired glucose tolerance and diabetes in humans.
- Fetal malnutrition during development is hypothesized to cause persistent beta-cell defects in the endocrine pancreas.
- Animal models of IUGR provide insights into beta-cell developmental programming, mirroring human metabolic disease associations.
Purpose of the Study:
- To review evidence linking human beta-cell dysfunction to low birth weight or IUGR.
- To evaluate animal models of IUGR for understanding beta-cell programming.
- To identify critical developmental periods and nutrient deficiencies affecting beta-cell function.
Main Methods:
- Review of human epidemiological data associating birth weight with metabolic health.
- Analysis of various animal models used to experimentally induce IUGR.
- Comparative assessment of methodologies and findings across different IUGR models and species.
Main Results:
- Evidence supports a connection between low birth weight/IUGR and human beta-cell dysfunction.
- Animal models demonstrate that IUGR can lead to beta-cell dysfunction and metabolic abnormalities in offspring.
- Mechanisms of beta-cell dysfunction vary across models due to differing IUGR induction methods and species-specific development.
Conclusions:
- Beta-cell developmental programming is influenced by fetal growth conditions.
- Understanding IUGR mechanisms is crucial for preventing metabolic diseases.
- Further research is needed to elucidate specific pathways of beta-cell dysfunction in human IUGR.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
